GLP-1 medications such as Mounjaro and Wegovy offer numerous advantages for achieving a healthy body weight, such as curbing your appetite and diminishing cravings. However, reducing food intake can make it challenging to fulfil nutritional needs. This is where supplements can be beneficial...

GLP-1 receptor agonists like Ozempic, Wegovy, Rybelsus, and Mounjaro have become popular for supporting weight loss... but what are the after effects on our skin?

Weight loss treatments have evolved rapidly in recent years, offering new hope for people seeking effective and convenient options. Eli Lilly’s newly FDA-approved oral tablet, Foundayo (orforglipron), joins this growing field as an alternative to injectable medications like Mounjaro and Wegovy, and in direct competition with Novo Nordisk's current offering of oral semaglutide (Ozempic/Wegovy), which is available in the UK as Rybelsus. Foundayo oral tablet close-up What is Fou

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with Semaglutide, the well-known active ingredient within Ozempic, Rybelsus and Wegovy.

Researchers found taking weight loss jabs was linked to a lower risk of mental health problems, including a 44% decreased risk of worsening depression associated with semaglutide (Ozempic, Rybelsus & Wegovy)

Many people experience significant weight loss using GLP-1 medications like Wegovy and Mounjaro. These drugs help control appetite and improve metabolism, making it easier to focus on losing weight. But what happens when the medication stops? Without a plan, the risk of regaining weight is high. This post explores how to maintain weight loss after stopping GLP-1 medications by focusing on healthy eating, nutrition, exercise, and mindset. Building sustainable habits is key to

Maintaining weight loss can be more challenging than losing the weight itself. Many people find that after reaching their target weight, old habits creep back in, and the scale starts to climb again. The key to lasting weight management lies in a balanced approach that includes changes in diet, gradual increases in exercise, and, when applicable, thoughtful adjustments to medications like Mounjaro or Wegovy.

GLP-1 medications like Mounjaro and Wegovy have become popular for managing weight and blood sugar levels. While effective, these drugs often come with side effects such as nausea, diarrhea, acid reflux, and sulphur burps. What many people don’t realize is that certain foods and drinks can make these side effects worse. In particular, diets high in saturated fats and sugary beverages like fizzy drinks and alcohol can increase discomfort. Understanding how these dietary choice

Weight loss is often seen as a quick fix, a goal to achieve through the latest fad diet or a new supplement. Yet, many people find themselves caught in a cycle of failed diets and temporary results. The truth is that lasting weight loss depends far more on changing your habits and mindset than on any short-term plan. Sustainable lifestyle changes build a foundation for long-term weight management and overall well-being. This post explores how shifting your mindset and devel

The US Food and Drug Administration (FDA) has approved a tablet version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. Although Oral Semaglutide is already on the market in the UK as the brand Rybelsus, this is currently licensed for Type 2 Diabetes. However, Rybelsus can be prescribed off-label for weight loss within the UK by a qualified healthcare professional, which is helpful for those who do not like injections or have needle phobia. Thi

Compared to Mounjaro, which also promotes weight loss, Semaglutide has a similar impact on ALT reduction. Both drugs improve liver enzymes by reducing fat and inflammation, but Semaglutide’s longer track record provides more data on liver outcomes.

A major new review has pitted the big three weight management products against each other – it looks at comparing the weight lost with each product and how long users were able to maintain their weight loss. There are several weight loss treatments now available in the UK via the NHS and private clinics Scientists compar ed tirzepatide – the active ingredient of Mounjaro – to semaglutide, which is in Wegovy and Ozempic, and liraglutide, that’s in Saxenda. he reviews – publish

A MAJOR review has pitted the big three blockbuster weight management jabs against each other – comparing weight lost and how long users were able to maintain it. There are several weight loss treatments now available in the UK via the NHS and private clinics Scientists compar ed tirzepatide – the active ingredient of Mounjaro – to semaglutide, which is in Wegovy and Ozempic, and liraglutide, that’s in Saxenda. he reviews – published in the gold-standard Cochrane Database of

Wegovy is compatible with vegetarian or vegan eating, but plan protein (beans, lentils, tofu/tempeh, mycoprotein), iron, iodine, calcium and B12 carefully — lower appetite can make hitting targets harder. A simple “protein first” rule at meals and a daily multivitamin that fits your diet can help, alongside routine blood work if your clinician advises. For coeliac disease or other medical diets, your team will integrate Wegovy around the existing plan rather than replace it.

Support starts with your prescribing service: nurse-led education, injection training, and scheduled reviews. Pharmacists can help with device checks, storage questions, and travel letters. Many NHS weight-management programmes offer dietitian input and behaviour support; local availability differs by nation and Integrated Care Board / health board. Stick to official resources for technique and safety; if something online conflicts with your pen’s leaflet or clinic advice, fo

Yes — psychological context matters. Calmer appetite can ease emotional or stress-linked eating, but it doesn’t replace mental-health care. Set expectations early, watch for mood changes, and use behavioural tools (meal planning, mindful eating, sleep routines). If you’ve had disordered-eating patterns, tell your clinician so support can be tailored; brief check-ins with a dietitian or counsellor often make the process smoother. Why psychology is part of treatment Weight mana

People sometimes call a plateau “tolerance,” but classic drug tolerance isn’t the main issue here. Signs to explore include hunger returning most days, cravings as frequent as before, or weight not trending down at agreed review points despite consistent dosing. Your team will check technique (hold time, site), missed doses, titration pace, meal structure, sleep, and interacting medicines. If you’re tolerating treatment but not seeing benefit, they may adjust the plan, hold a

Yes — seasonal extremes matter. In summer, protect pens from heat; don’t leave them in cars or direct sun, and use an insulated pouch for journeys. In winter, guard against freezing (a frozen pen must not be used). Unopened pens stay refrigerated; in-use pens can usually be kept below 30 °C for the leaflet-specified period, cap on and away from light. If you suspect overheating or freezing, ask your pharmacist before using the pen. Why temperature control matters Wegovy (sema

Weight loss with Wegovy can lower blood pressure and improve metabolic markers, so clinicians often monitor and adjust existing treatments over time. If you use insulin or sulphonylureas for diabetes, doses may need review to reduce hypos as appetite and intake fall. Wegovy can slow stomach emptying, so timing may be adjusted for oral medicines that require predictable absorption. Always share a full medication list; Scotland and Wales follow similar clinical principles, thou

Yes — many services use Wegovy for maintenance when it remains clinically appropriate and well tolerated, but continuation depends on local commissioning rules. Some pathways set time limits or review benchmarks; others allow ongoing use if benefits and safety are clear. Whatever the policy, maintenance also relies on stable habits (protein, fibre, steps, simple strength work) so that stopping — if and when it happens — doesn’t trigger rapid regain. Scotland and Wales may fra